MolNFT v1 · #78890 · protein
Human pantothenate kinase 3 in complex with a pantothenate analog
3SMS: “Human pantothenate kinase 3 in complex with a pantothenate analog”. X-ray diffraction, 3 ligands (ADP, RNH, UNX), 5 pockets (best druggability 0.67). MolNFT v1 #78890 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 3SMS
- Type
- protein
- Length
- 351 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Pantothenate kinase 3
- EC
- 2.7.1.33
- UniProt
- Q9H999
- Ligands
- ADP, RNH, UNX
- Pockets
- 5 · best druggability 0.67
Structure
x-ray diffraction · 1 distinct chain · 42% helix, 26% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Pantothenate kinase 3 (EC 2.7.1.33) | protein | 351 | 42% helix, 26% strand | Q9H999 |
Ligands and binding sites
- ADP · Adenosine-5'-diphosphate · ligand · chains A
- RNH · (2R)-N-[3-(heptylamino)-3-oxopropyl]-2,4-dihydroxy-3,3-dimethylbutanamide · ligand · chains A
- UNX · Unknown atom or ion · ion · 11 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 242 | 0.67 | 0.83 | 30 | UNX |
| 2 | 284 | 0.65 | 0.82 | 41 | ADP, UNX |
| 3 | 273 | 0.54 | 0.75 | 31 | UNX |
| 4 | 127 | 0.48 | 0.78 | 15 | empty |
| 5 | 52 | 0.40 | 0.82 | 18 | empty |
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q9H999
- Elsewhere: RCSB PDB 3SMS · PDBe 3SMS · UniProt Q9H999
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.